ResMed Buy Hold or Sell Recommendation

RMD -- USA Stock  

USD 115.36  1.37  1.20%

Considering 30-days investment horizon, and your above average risk tolerance our recommendation regarding ResMed is 'Strong Buy'. Macroaxis provides ResMed buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ResMed positions. The advice algorithm takes into account all of ResMed available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from ResMed buy-and-hold prospective. Additionally take a look at ResMed Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool.

Time Horizon

Risk Tolerance

Execute Advice
Sell ResMedBuy ResMed
Strong Buy


Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Piotroski F Score

Financial Leverage

For the selected time horizon ResMed has a risk adjusted performance of 0.01, jensen alpha of 0.0, total risk alpha of 0.0 and treynor ratio of 0.0
Macroaxis provides advice on ResMed to complement and cross-verify current analyst consensus on ResMed. Our recommendation engine determines the corporation potential to grow exclusively from the prospective of investors current risk tolerance and investing horizon. To make sure ResMed is not overpriced, please check all ResMed fundamentals including its Revenue, Current Ratio, Market Capitalization, as well as the relationship between Cash and Equivalents and Earnings Per Share . Given that ResMed has Price to Earning of 52.68 times, we recommend you check out ResMed market performance and probability of bankruptcy to make sure the company can sustain itself in the current economic cycle given your recent risk tolerance and investing horizon.

ResMed Thematic Classifications

Obamacare Repeal IdeaObamacare Repeal
Large healthcare related equities associated with Obamacare

ResMed Returns Distribution Density

Mean Return0.19Value At Risk0.88
Potential Upside1.82Standard Deviation0.83
 Return Density 

Institutional Investors

Security TypeSharesValue
Vanguard Group IncCommon Shares14.5 M1.5 B
Capital World InvestorsCommon Shares11.6 M1.2 B
Blackrock IncCommon Shares11 M1.1 B
Fmr LlcCommon Shares8.1 M836.1 M
State Street CorpCommon Shares5.5 M571.5 M
Baillie Gifford CoCommon Shares4.8 M500 M
Geode Capital Management LlcCommon Shares1.8 M182.2 M

ResMed Greeks

Alpha over DOW
Beta against DOW=0.00
Overall volatility
Information ratio =0.00

ResMed Volatility Alert

ResMed exhibits relatively low volatility with skewness of 0.67 and kurtosis of 0.87. However, we advice investors to further investigate ResMed to make sure all market statistics is disseminated and is consistent with investors' estimations about ResMed upside potential.
 Better Than Average     
 Worse Than Average Compare ResMed to competition

ResMed Fundamental Vs Peers

FundamentalsResMedPeer Average
Return On Equity15.70 % (15.17) %
Return On Asset10.72 % (15.64) %
Profit Margin13.49 % (5.50) %
Operating Margin29.07 % (10.91) %
Current Valuation16.33 B152.14 B
Shares Outstanding142.74 M1.43 B
Shares Owned by Insiders1.17 % 6.91 %
Shares Owned by Institutions66.82 % 18.37 %
Number of Shares Shorted2.99 M3.24 M
Price to Earning52.68 times40.69 times
Price to Book7.99 times14.44 times
Price to Sales7.04 times17.81 times
Revenue2.34 B9.85 B
Gross Profit1.36 B21.75 B
EBITDA680.22 M1.41 B
Net Income315.59 M517.71 M
Cash and Equivalents188.7 M3.89 B
Cash per Share1.32 times5.17 times
Total Debt281.45 M7.36 B
Debt to Equity13.60 % 0.72 %
Current Ratio2.09 times3.30 times
Book Value Per Share14.43 times13.64 times
Cash Flow from Operations514.07 M1.25 B
Short Ratio3.88 times2.09 times
Earnings Per Share2.19 times2.30 times
Price to Earnings To Growth4.12 times1.22 times
Number of Employees5.94 K10.67 K
Market Capitalization16.47 B29.78 B
Total Asset3.26 B126.86 B
Retained Earnings2.16 B38.24 B
Working Capital781.73 M3.58 B
Current Asset1.42 B36.8 B
   ResMed exotic insider transaction detected [view details]

ResMed Market Momentum

ResMed Alerts

Trading Alerts and Improvement Suggestions

About 67.0% of the company shares are owned by institutional investors
On August 15, 2018 ResMed paid $ 0.37 per share dividend to its current shareholders
Latest headline from MacroaxisInsider: Payment of 14546 shares by Michael Farrell of ResMed subject to Rule 16b-3

Latest Analysts View

ResMed Current Analysts Recommendations

Target Median Price105.50
Target Mean Price104.69
Recommendation Mean2.60
Target High Price125.00
Number Of Analyst Opinions8
Target Low Price75.00
Additionally take a look at ResMed Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool. Please also try Watchlist Optimization module to optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm.